Table 1.
Administration | Strength/pack | Hospital prices—5%, unit cost (€) | Cost per mg (€) | |
---|---|---|---|---|
Irinotecana | IV | 20 mg/ml × 15 ml | 147.31 | 0.47 |
Folinic acida | IV | 10 mg/ml × 20 ml | 11.2 | 0.03 |
Fluorouracila | IV | 50 mg/ml × 100 ml | 14.14 | 0.0028 |
Cetuximab | IV | 5 mg/ml × 20 ml | 132.26 | 1.32 |
Panitumumab | IV | 20 mg/ml × 20 ml | 1100.28 | 2.75 |
Bevacizumab | IV | 25 mg/ml × 4ml | 204.52 | 2.05 |
Aflibercept | Intravitreal | 25 mg/ml × 4 ml | 250.27 | 2.50 |
Oxaliplatin | IV | 5 mg/ml × 10 ml | 19.82 | 0.40 |
Capecitabine | Oral | 150 mg/tab × 60 tabs | 10.66 | 0.002 |
Nivolumab | IV | 10 mg/ml × 24 ml | 2106.87 | 8.78 |
Pembrolizumab | IV | 25 mg/ml × 4 ml | 2229.89 | 22.30 |
Encorafenib | Oral | 75 mg/ml × 42 caps | 1046.92 | 0.33 |
Tas102 (Trifluridine-tiporacil) | Oral | (15 + 6.14) mg/tab × 20 tabs | 445.92 | 1.05 |
Regorafenib | Oral | 40 mg/tab × 84 tabs | 1884.71 | 0.56 |
Mitomycin-C | IV | 2 mg/vial × 10 vials | 15.91 | 0.84 |
For dosing schedules dependent on body weight or surface area, an average body weight of 70.7 kg and body surface area of 1.79 m2 were used
aIn the cases of Irinotecan, Folinic acid and Fluorouracil the cost per mg reflects the average price of generics/off patent which was used in the analysis